IL-33 induces innate lymphoid cell–mediated airway inflammation by activating mammalian target of rapamycin
Open Access
- 30 November 2012
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 130 (5), 1159-1166.e6
- https://doi.org/10.1016/j.jaci.2012.05.018
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust
- Medical Research Council
- Wellcome Trust
- Medical Research Council
- European Respiratory Society
This publication has 46 references indexed in Scilit:
- Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunityJournal of Allergy and Clinical Immunology, 2012
- TOR in the immune systemCurrent Opinion in Cell Biology, 2011
- An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammationNature Immunology, 2011
- Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunityNature Immunology, 2011
- IL-33 family members and asthma – bridging innate and adaptive immune responsesCurrent Opinion in Immunology, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Molecular mechanisms of mTOR-mediated translational controlNature Reviews Molecular Cell Biology, 2009
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007